Skip to main content

The DC-ren partner mosaiques diagnostics provides highly innovative Clinical Proteomics services for academic institutions and pharmaceutical companies

By February 12, 2024March 4th, 2024For the public & patients, Physicians & academics

First health insurance company in Germany pays for luxury urine test.

Hope for kidney patients. The test recognizes illnesses before they become a problem.

Proteome analysis can be used to detect kidney disease, heart disease, bladder cancer and benign and aggressive prostate cancer.

Newspaper article from Jana Quoos


Link to publication

EU Flag DC-ren | Medical University Innsbruck

DC-ren has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 848011.